Audited Supplier
75mg
Internal Medicine
For oral administration
Elderly, Adult
Solid
Capsules
Organic Chemicals
Chemical Synthesis
Voice-Bio
Carton
75mg 3*10capsules/box
China
3004909099
Product Description
Clopidogrel Bisulfate Tablets
Therapeutic indications
Prevention of vascular ischaemia associated with secondary atherothrombotic events (MI,
stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.
Acute coronary syndrome
Clopidogrel is indicated in combination with aspirin for patients with:
• Unstable angina or non-ST elevation MI. Clopidogrel is indicated for early and long-term
reduction of atherothrombotic events (myocardial infarction, stroke, vascular death and
refractory ischaemia) whether or not patients undergo cardiac revascularisation (surgical
or PCI, with or without stent).
• ST-segment elevation acute myocardial infarction. In this population, clopidogrel has been
shown to reduce the rate of death from any cause and the rate of a combined endpoint of
death, re-infarction or stroke.
Dose and method of administration
Clopidogrel should be taken once a day with or without food.
Adults
Generally, clopidogrel should be given as a single daily dose of 75 mg.
In patients with acute coronary syndrome:
• unstable angina or non-ST elevation myocardial infarction - clopidogrel treatment should
be initiated with a single 300 mg loading dose and then continued long-term at 75 mg once
a day (with aspirin 75 mg-325 mg daily).
• ST elevation acute myocardial infarction - clopidogrel treatment should be given as a single
daily dose of 75 mg initiated with or without a 300 mg loading dose in combination with
aspirin and with or without thrombolytics.
No dosage adjustment is necessary for either elderly patients or patients with renal impairment
Children and adolescents
Safety and efficacy in subjects below the age of 18 have not been established.
****Follow all directions given to you by your doctor and pharmacist carefully
Packaging & Shipping
Certifications
Business License, Manufacturing License, Certificate of Pharmaceutical Products (CoPP), Free Sales Certificate (FSC), and technical documents for registration.
Our Service
1.Mixed container, we can mix different items in one container.
2.Free professional and creative artwork design.
3.OEM service.
4.Registration documents supported.
5.Packing as your request, with photo before shipment.
We will spare no efforts to meet your demands!
please feel free to contact us
Address: 298 West Zhongshan Road, Ningbo, P.R. China
Attn: Mr. Medic Ren
| Specification | 75mg 3*10capsules/box |
| Shelf life | 3years |
| Storage | Store in a cool and dry place below 25ºC |
Therapeutic indications
Prevention of vascular ischaemia associated with secondary atherothrombotic events (MI,
stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.
Acute coronary syndrome
Clopidogrel is indicated in combination with aspirin for patients with:
• Unstable angina or non-ST elevation MI. Clopidogrel is indicated for early and long-term
reduction of atherothrombotic events (myocardial infarction, stroke, vascular death and
refractory ischaemia) whether or not patients undergo cardiac revascularisation (surgical
or PCI, with or without stent).
• ST-segment elevation acute myocardial infarction. In this population, clopidogrel has been
shown to reduce the rate of death from any cause and the rate of a combined endpoint of
death, re-infarction or stroke.
Dose and method of administration
Clopidogrel should be taken once a day with or without food.
Adults
Generally, clopidogrel should be given as a single daily dose of 75 mg.
In patients with acute coronary syndrome:
• unstable angina or non-ST elevation myocardial infarction - clopidogrel treatment should
be initiated with a single 300 mg loading dose and then continued long-term at 75 mg once
a day (with aspirin 75 mg-325 mg daily).
• ST elevation acute myocardial infarction - clopidogrel treatment should be given as a single
daily dose of 75 mg initiated with or without a 300 mg loading dose in combination with
aspirin and with or without thrombolytics.
No dosage adjustment is necessary for either elderly patients or patients with renal impairment
Children and adolescents
Safety and efficacy in subjects below the age of 18 have not been established.
****Follow all directions given to you by your doctor and pharmacist carefully
Packaging & Shipping
| Comercial Packing | or Customized |
| Production Time | About 30-60days after artwork confirmed |
CertificationsBusiness License, Manufacturing License, Certificate of Pharmaceutical Products (CoPP), Free Sales Certificate (FSC), and technical documents for registration.
Since 2015, NINGBO VOICE BIOCHEMIC CO. LTD. is a professional company to offer one-package service for FPP (Finished Pharmaceutical Products ); APIs (Active Pharmaceutical Ingredients); (Pharmaceutical Intermediates ); Veterinary Pharmaceuticals.that meet of Standard GMP and current BP,USP version.
Our Service
1.Mixed container, we can mix different items in one container.
2.Free professional and creative artwork design.
3.OEM service.
4.Registration documents supported.
5.Packing as your request, with photo before shipment.
We will spare no efforts to meet your demands!
please feel free to contact us
Address: 298 West Zhongshan Road, Ningbo, P.R. China
Attn: Mr. Medic Ren
